glp 1 efectos secundarios Guía completa sobre los análogos del GLP-1: Ozempic, Wegovy, Mounjaro y Saxenda ✨ **Minimiza los efectos adversos
Description
2022;14:e32610
Subsequently, the drug has been approved across the European Union (September 2022), Canada (November 2022), and Australia (December 2022)
Dosages: We also began to see products pop up on the market in dosages that werent specified by the manufacturer, and have never been tested for safety or efficacy
The tendencies in the timing of biomarker measurement were similar regardless of treatment, although metformin initiators had a higher probability of having their biomarker levels measured in general (Figure S8)
It may provide an alternative option if approved
